MedTrace Logo

Analgesic Effect of Levobupivacaine in Breast Augmentation

NCT02465008 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2016-07-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation

Conditions

Interventions

DRUG

Levobupivacaine

DRUG

Placebo

Sponsors & Collaborators

  • General University Hospital of Valencia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2016-07-31
Completion
2016-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465008 on ClinicalTrials.gov